Piedmont Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-34,123
Closed -$3.35M 716
2020
Q1
$3.35M Buy
34,123
+30,151
+759% +$3.95M 0.13% 150
2019
Q4
$577K Buy
3,972
+680
+21% +$93.9K 0.02% 467
2019
Q3
$439K Buy
3,292
+176
+6% +$22.7K 0.02% 576
2019
Q2
$356K Sell
3,116
-287
-8% -$33.6K 0.01% 690
2019
Q1
$422K Buy
3,403
+279
+9% +$31.7K 0.02% 609
2018
Q4
$315K Buy
3,124
+946
+43% +$106K 0.02% 687
2018
Q3
$278K Sell
2,178
-274
-11% -$32.6K 0.01% 815
2018
Q2
$265K Buy
+2,452
New +$267K 0.01% 704
2017
Q1
Sell
-577
Closed -$57.8K 643
2016
Q4
$57.8K Buy
+577
New +$61.8K ﹤0.01% 427
2014
Q3
Sell
-403
Closed -$40.6K 350
2014
Q2
$40.6K Sell
403
-38
-9% -$3.71K ﹤0.01% 184
2014
Q1
$40.5K Sell
441
-26
-6% -$2.4K ﹤0.01% 187
2013
Q4
$42.2K Sell
467
-20
-4% -$1.73K ﹤0.01% 179
2013
Q3
$38.9K Hold
487
﹤0.01% 174
2013
Q2
$35.4K Buy
+487
New +$36.4K ﹤0.01% 231

Other funds holding ZBH

Piedmont Investment Advisors's ZBH Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Zimmer Biomet (ZBH) in Q2 2020, closing a stake of 34,123 shares — an estimated $3.35M sold.

Piedmont Investment Advisors first reported a position in ZBH in Q2 2013 and held it in 14 quarters. The position peaked at $3.35M in Q1 2020. 945 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Zimmer Biomet position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 34,123 Zimmer Biomet shares in Q2 2020, an estimated $3.35M.
  • Piedmont Investment Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 14 quarters.
  • Piedmont Investment Advisors's Zimmer Biomet position peaked at $3.35M in Q1 2020.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.